(MRK) Merck KGaA - Performance -31.7% in 12m
MRK performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-10.60%
#70 in Peer-Group
Rel. Strength
17.63%
#6266 in Stock-Universe
Total Return 12m
-31.72%
#134 in Peer-Group
Total Return 5y
22.95%
#51 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 18.0 |
| P/E Forward | 12.9 |
| High / Low | EUR |
|---|---|
| 52 Week High | 172.66 EUR |
| 52 Week Low | 108.89 EUR |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 30.09 |
| Buy/Sell Signal +-5 | -0.39 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MRK (-31.7%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: MRK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for MRK
| Total Return (including Dividends) | MRK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -0.52% | 4.35% | 1.11% |
| 3 Months | -14.06% | -6.89% | 5.58% |
| 12 Months | -31.72% | -5.08% | 10.51% |
| 5 Years | 22.95% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | MRK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 18.1% | 65.8% | 69.9% |
| 3 Months | -53.1% | -72% | 69.3% |
| 12 Months | -90.4% | -62.2% | 43.2% |
| 5 Years | 2.5% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #122 | -4.66% | -1.61% |
| 3 Month | #142 | -7.70% | -18.60% |
| 12 Month | #133 | -28.07% | -38.22% |
| 5 Years | #53 | -18.32% | -41.21% |
FAQs
Does Merck KGaA (MRK) outperform the market?
No,
over the last 12 months MRK made -31.72%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months MRK made -14.06%, while XLV made -6.89%.
Performance Comparison MRK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MRK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.5% | -1.6% | -15.9% | -42% |
| US NASDAQ 100 | QQQ | -0.3% | -2% | -15.1% | -41% |
| German DAX 40 | DAX | 1.7% | 0.2% | -32.3% | -61% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.2% | 0.4% | -17.7% | -43% |
| Hongkong Hang Seng | HSI | -1% | -5.6% | -34.9% | -59% |
| India NIFTY 50 | INDA | 1.2% | 0.8% | -14.9% | -30% |
| Brasil Bovespa | EWZ | -2.8% | -1% | -36.1% | -41% |
MRK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.2% | -2% | -18.7% | -54% |
| Consumer Discretionary | XLY | 0.1% | 1.3% | -6% | -49% |
| Consumer Staples | XLP | -0.2% | -0.3% | -17.4% | -39% |
| Energy | XLE | -6.4% | -3.4% | -19.5% | -35% |
| Financial | XLF | 1.1% | 2.1% | -18.7% | -55% |
| Health Care | XLV | -2.4% | -4.9% | -15.4% | -27% |
| Industrial | XLI | 0.5% | -0.9% | -21.5% | -50% |
| Materials | XLB | 0.2% | -1.9% | -16.7% | -31% |
| Real Estate | XLRE | -1% | -1.5% | -16.9% | -45% |
| Technology | XLK | -0.8% | -2.5% | -16.3% | -36% |
| Utilities | XLU | -1.9% | -1.1% | -24.3% | -53% |
| Aerospace & Defense | XAR | 0.5% | -6.3% | -32.8% | -74% |
| Biotech | XBI | -0.2% | -8.3% | -5.1% | -24% |
| Homebuilder | XHB | 1.1% | 4.5% | -0.5% | -22% |
| Retail | XRT | 3.4% | -0.4% | -8% | -32% |
MRK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -12.3% | -19.2% | -25.8% | -35% |
| Natural Gas | UNG | 0.3% | 2.1% | -34.2% | -17% |
| Gold | GLD | -4.1% | -6.7% | -46.1% | -79% |
| Silver | SLV | 0.3% | -11.9% | -35.5% | -54% |
| Copper | CPER | 2% | -2.2% | -30.8% | -40% |
MRK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2% | -1.2% | -14.5% | -28% |
| iShares High Yield Corp. Bond | HYG | -1% | -1% | -19.6% | -41% |